Simvastatin does not inhibit intimal hyperplasia and restenosis but promotes plaque regression in normocholesterolemic patients undergoing coronary stenting: A randomized study with intravascular ultrasound
- 1 March 2005
- journal article
- clinical trial
- Published by Elsevier in American Heart Journal
- Vol. 149 (3) , 520-526
- https://doi.org/10.1016/j.ahj.2004.10.032
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- One-Year Clinical Results With the Slow-Release, Polymer-Based, Paclitaxel-Eluting TAXUS StentCirculation, 2004
- Sirolimus-Eluting Stents versus Standard Stents in Patients with Stenosis in a Native Coronary ArteryNew England Journal of Medicine, 2003
- Evaluation of coronary remodeling after Sirolimus-Eluting stent implantation by serial Three-Dimensional intravascular ultrasoundThe American Journal of Cardiology, 2003
- Mechanisms of plaque stabilization with statinsThe American Journal of Cardiology, 2003
- Statin treatment following coronary artery stenting and one-year survivalJournal of the American College of Cardiology, 2002
- Patterns and Mechanisms of In-Stent RestenosisCirculation, 1996
- Lack of Effect of Lovastatin on Restenosis after Coronary AngioplastyNew England Journal of Medicine, 1994
- A Comparison of Balloon-Expandable-Stent Implantation with Balloon Angioplasty in Patients with Coronary Artery DiseaseNew England Journal of Medicine, 1994
- A Randomized Comparison of Coronary-Stent Placement and Balloon Angioplasty in the Treatment of Coronary Artery DiseaseNew England Journal of Medicine, 1994
- Simvastatin but not pravastatin has a direct inhibitory effect on rat and human myocyte proliferationClinical Biochemistry, 1992